98 related articles for article (PubMed ID: 25960192)
1. Impact of ethnicity and race on response to Angiotensin-converting enzyme inhibitors in heart failure.
Campbell P; Ventura HO
J Card Fail; 2015 Jun; 21(6):457-9. PubMed ID: 25960192
[No Abstract] [Full Text] [Related]
2. Addition of Angiotensin-Converting Enzyme Inhibitors to Beta-Blockers Does Not Have a Distinct Effect on Hispanics Compared With African Americans and Whites With Heart Failure and Reduced Ejection Fraction.
Kaufman JS
J Card Fail; 2015 Nov; 21(11):935. PubMed ID: 26300112
[No Abstract] [Full Text] [Related]
3. Comparing antihypertensive agents.
Koleszar N
Can Fam Physician; 1998 Jun; 44():1235, 1237. PubMed ID: 9640514
[No Abstract] [Full Text] [Related]
4. Pharmacogenetic interactions between angiotensin-converting enzyme inhibitor therapy and the angiotensin-converting enzyme deletion polymorphism in patients with congestive heart failure.
McNamara DM; Holubkov R; Postava L; Janosko K; MacGowan GA; Mathier M; Murali S; Feldman AM; London B
J Am Coll Cardiol; 2004 Nov; 44(10):2019-26. PubMed ID: 15542286
[TBL] [Abstract][Full Text] [Related]
5. Treatment of congestive heart failure. Has the time come for decreased complexity?
Rydén L; Remme WJ
Eur Heart J; 1999 Jun; 20(12):867-71. PubMed ID: 10329091
[No Abstract] [Full Text] [Related]
6. Beta-adrenergic receptor blockade and the angiotensin-converting enzyme deletion polymorphism in patients with chronic heart failure.
de Groote P; Helbecque N; Lamblin N; Hermant X; Amouyel P; Bauters C; Dallongeville J
Eur J Heart Fail; 2004 Jan; 6(1):17-21. PubMed ID: 15012914
[TBL] [Abstract][Full Text] [Related]
7. Effect of the addition of a beta-blocker on left ventricular remodeling and prognosis in patients with dilated cardiomyopathy treated with angiotensin-converting enzyme inhibitor.
Hamada M; Hara Y; Ohtsuka T; Suzuki J; Saeki H; Ogimoto A; Shigematsu Y
J Cardiovasc Pharmacol; 2003 Jan; 41 Suppl 1():S5-10. PubMed ID: 12688389
[TBL] [Abstract][Full Text] [Related]
8. ACE inhibitors and beta blockers in chronic congestive cardiac failure: therapeutic basis.
Manoria PC; Manoria P
J Indian Med Assoc; 2003 May; 101(5):311-2, 315. PubMed ID: 14575221
[TBL] [Abstract][Full Text] [Related]
9. Mechanistic and clinical rationales for using beta-blockers in heart failure.
Bristow MR
J Card Fail; 2000 Jun; 6(2 Suppl 1):8-14. PubMed ID: 10908093
[TBL] [Abstract][Full Text] [Related]
10. Treatment of heart failure with ACE inhibitors and beta-blockers: what is next? AT1-receptor antagonists?
Hoppe UC
Clin Res Cardiol; 2007 Apr; 96(4):196-8. PubMed ID: 17294351
[No Abstract] [Full Text] [Related]
11. Beta-blockers vs. angiotensin-converting enzyme inhibitors in hypertension: effects on left ventricular hypertrophy.
Gosse P; Roudaut R; Herrero G; Dallocchio M
J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S145-50. PubMed ID: 11527119
[TBL] [Abstract][Full Text] [Related]
12. Impact of initiating carvedilol before angiotensin-converting enzyme inhibitor therapy on cardiac function in newly diagnosed heart failure.
Sliwa K; Norton GR; Kone N; Candy G; Kachope J; Woodiwiss AJ; Libhaber C; Sareli P; Essop R
J Am Coll Cardiol; 2004 Nov; 44(9):1825-30. PubMed ID: 15519014
[TBL] [Abstract][Full Text] [Related]
13. Dismantling mandates in the treatment of heart failure.
Leier CV
J Am Coll Cardiol; 2004 Nov; 44(9):1831-3. PubMed ID: 15519015
[No Abstract] [Full Text] [Related]
14. MY APPROACH to the patient with heart failure and improved ejection fraction
Cohn JN
Trends Cardiovasc Med; 2018 Feb; 28(2):153. PubMed ID: 29032935
[No Abstract] [Full Text] [Related]
15. Pharmacologic management of heart failure: neurohormonal agents.
Moser DK
Crit Care Nurs Clin North Am; 1993 Dec; 5(4):599-608. PubMed ID: 7905275
[TBL] [Abstract][Full Text] [Related]
16. Effect of statins, angiotensin-converting enzyme inhibitors, and beta blockers on survival in patients >or=65 years of age with heart failure and preserved left ventricular systolic function.
Shah R; Wang Y; Foody JM
Am J Cardiol; 2008 Jan; 101(2):217-22. PubMed ID: 18178410
[TBL] [Abstract][Full Text] [Related]
17. Contemporary medical management of left ventricular dysfunction and congestive heart failure.
Teo KK; Ignaszewski AP; Gutierrez R; Hill KL; Martin SL; Calhoun HP; Humen DP; Montague TJ
Can J Cardiol; 1992; 8(6):611-9. PubMed ID: 1354569
[TBL] [Abstract][Full Text] [Related]
18. Blockade of the renin-angiotensin system. Effect on mortality in patients with left ventricular systolic dysfunction.
Pitt B
Cardiol Clin; 1994 Feb; 12(1):101-14. PubMed ID: 8181019
[TBL] [Abstract][Full Text] [Related]
19. Beta blockers or angiotensin-converting-enzyme inhibitor/angiotensin receptor blocker: what should be first?
Remme WJ
Cardiol Clin; 2007 Nov; 25(4):581-94; vii. PubMed ID: 18063162
[TBL] [Abstract][Full Text] [Related]
20. Carvedilol: use in chronic heart failure.
Doughty RN; White HD
Expert Rev Cardiovasc Ther; 2007 Jan; 5(1):21-31. PubMed ID: 17187454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
